RIVM recommends more stringent EU standards BPA More stringent European standards for safe exposure of workers and consumers to bisphenol A (BPA) were proposed in 2014 and 2015.
Nanotechnology increasingly used in medical devices The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.
Interspecies website transferred from RIVM to Utrecht University The Interspecies website which helps researchers to reduce and refine the use of laboratory animals is transferred to the 3Rs database Programme of the 3Rs-Centre Utrecht Life Sciences (ULS) of Utr
National Heat Plan active The National Heat Plan became active in the Netherlands on June 30th. This means that it is necessary to take preventive health measures for vulnerable groups.
Icy air measurements Bernice Notenboom’s Arctic March expedition team has reached the summit of Greenland. She has conquered the 3500-metre high summit on Greenland with functioning air measuring equipment.
Climate reporter Bernice Notenboom arrives in Greenland for continuation of climate expedition Climate reporter and expedition leader Bernice Notenboom and her team left for Greenland on 4 May 2015 for the second part of the Arctic March.
New insights on ammonia emissions Calculated ammonia emissions in the Netherlands are still declining. However, emissions overall are greater than previously assumed.
Big Data gives more insight into the health impacts of air pollution Long-term exposure to particulate air pollution and nitrogen dioxide has been found to be associated with total mortality and mortality from respiratory diseases and lung cancer in the Netherlands.
Risk of degradation of European ecosystems by air pollution is decreasing The number of natural areas in Europe that are threatened by air pollution will decrease between 2005 and 2020.
RIVM participates in large EU project to head up global fight against infectious diseases COMPARE, a large EU project intends to speed up the detection of, and response to disease outbreaks among humans and animals worldwide, through the use of new genome technology.